A common variant of CDKN2A (p16) predisposes to breast cancer

被引:61
|
作者
Debniak, T
Górski, B
Huzarski, T
Byrski, T
Cybulski, C
Mackiewicz, A
Gozdecka-Grodecka, S
Gronwald, J
Kowalska, E
Haus, O
Grzybowska, E
Stawicka, M
Swiec, M
Urbanski, K
Niepsuj, S
Wasko, B
Gózdz, S
Wandzel, P
Szczylik, C
Surdyka, D
Rozmiarek, A
Zambrano, O
Posmyk, M
Narod, SA
Lubinski, J
机构
[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[2] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[3] Dept Canc Immunol, Poznan, Poland
[4] Dept Clin Genet, Bydgoszcz, Poland
[5] Maria Sklodowska Curie Inst, Dept Tumour Biol, Gliwice, Poland
[6] Prophylact & Epidemiol Ctr, Poznan, Poland
[7] Reg Oncol Hosp, Opole, Poland
[8] Reg Oncol Ctr, Krakow, Poland
[9] Reg Oncol Hosp, Olsztyn, Poland
[10] Reg Hosp, Rzeszow, Poland
[11] Holycross Oncol Ctr, Kielce, Poland
[12] Reg Hosp, Bielsko Biala, Poland
[13] Mil Hosp, Warsaw, Poland
[14] Reg Hosp, Lublin, Poland
[15] Reg Oncol Hosp, Zielona Gora, Poland
[16] Reg Hosp, Lodz, Poland
[17] Reg Oncol Hosp, Bialystok, Poland
关键词
D O I
10.1136/jmg.2005.031476
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, Objective: To determine whether this variant also predisposes to breast cancer. Methods: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. Results: The odds ratio ( OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 ( p = 0.002) and after age 50 it was 1.3 ( p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 ( OR = 3.8; p = 0.0002). Conclusions: CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.
引用
收藏
页码:763 / 765
页数:3
相关论文
共 50 条
  • [1] The CDKN2A (p16) Gene and Human Cancer
    William D. Foulkes
    Tamar Y. Flanders
    Pamela M. Pollock
    Nicholas K. Hayward
    Molecular Medicine, 1997, 3 : 5 - 20
  • [2] The CDKN2A (p16) gene and human cancer
    Foulkes, WD
    Flanders, TY
    Pollock, PM
    Hayward, NK
    MOLECULAR MEDICINE, 1997, 3 (01) : 5 - 20
  • [3] CDKN2A/p16 in ependymomas
    Simona Bortolotto
    Loredana Chiadò-Piat
    Paola Cavalla
    Ivana Bosone
    Alessandro Mauro
    Davide Schiffer
    Journal of Neuro-Oncology, 2001, 54 : 9 - 13
  • [4] CDKN2A/p16 in ependymomas
    Bortolotto, S
    Chiadò-Piat, L
    Cavalla, P
    Bosone, I
    Mauro, A
    Schiffer, D
    JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (01) : 9 - 13
  • [5] CDKN2A/p16 evaluation in cytology specimens
    Xing, Juan
    Griffith, Christopher C.
    CANCER CYTOPATHOLOGY, 2023, 131 (11) : 672 - 676
  • [6] CDKN2A/P16 expression in mycosis fungoides
    Fargnoli, MC
    Chimenti, S
    Stanta, G
    Bonin, S
    Amantea, A
    Felli, A
    Peris, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 487 - 487
  • [7] CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
    Bortolotto, S
    Chiadò-Piat, L
    Cavalla, P
    Bosone, I
    Chiò, A
    Mauro, A
    Schiffer, D
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (04) : 554 - 557
  • [8] CDKN2A/p16 is inactivated by the combination of inversion and translocation
    Norris, Alexis L.
    Kamiyama, Hirohiko
    Hruban, Ralph H.
    Eshleman, James R.
    CANCER RESEARCH, 2015, 75
  • [9] Implications of P16/CDKN2A deletion in pleural mesotheliomas
    Ladanyi, M
    LUNG CANCER, 2005, 49 : S95 - S98
  • [10] Inactivation of CDKN2A gene (p16) in gallbladder carcinoma
    Roa, JC
    Vo, Q
    Araya, JC
    Villaseca, M
    Guzmán, P
    Ibacache, G
    de Aretxabala, X
    Roa, I
    REVISTA MEDICA DE CHILE, 2004, 132 (11) : 1369 - 1376